Vitiligo Biomarker CXCL10 Correlates With Clinical Response to Ruxolitinib Cream in the Phase 2 Randomized TRuE-V Mechanism-of-Action Study.
T. Passeron
M. Lebwohl
C. Lynde
M. S. Alam
V. Laquer
J. Beecker
A. Ganesan
C. Timmers
Angelina Volkova
Babak Soltanalizadeh
D. Kornacki
Susan H. Smith
Medicine